Breaking News, Collaborations & Alliances

Clinigen Extends Agreement with Accord Health

The agreement now covers Accord’s European Solid Dose Products, including those in the central nervous system, autoimmune, diabetes and anti-viral therapy areas

Clinigen Group has announced that its Clinical Trial Service (‘CTS’) business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand’ service to Accord’s products, a first for the industry.   Clinigen and Accord have been partnered since 2012 to deliver oncology Injectable Products, including carboplatin, cisplatin and paclitaxel, into clinical trials. The extended agreement now covers Accord’s ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters